Q3 Results Highlights: Cyient Falls 23%, Dr. Reddy’s Slips, IndiGo Reports Robust Growth

On January 24, 2025, Cyient's stock nosedived 23% after reporting a 16.92% YoY drop in profit to ₹122.3 crore, despite a 5.76% revenue uptick to ₹1,926.4 crore. Dr. Reddy's shares declined 6%, falling short of profit expectations due to North American pricing pressures.

Spandana Sphoorty, Adani Energy Solutions, and Granules India saw declines, reflecting broader market challenges. However, IndiGo posted strong Q3 results, with a 15% YoY rise in net profit driven by higher passenger traffic and cost control measures. The airline's stock gained investor confidence, highlighting optimism in the aviation sector.

These mixed results underscore varying fortunes across industries amid economic headwinds.

Source: LiveMint, Reuters.